Mohamdeen, Youssra Moustafa GadelkareemTabriz, Atabak GhanizadehTighsazzadeh, MohammadNandi, UttomKhalaj, RoxanneAndreadis, IoannisBoateng, Joshua SDouroumis, Dennis2021-12-272021-12-2720/12/2021https://doi.org/10.1093/jpp/rgab173https://bit.ly/32ydsp0Objectives The aim of the work was to introduce 3D printing technology for the design and fabrication of drug-eluting contact lenses (DECL) for the treatment of glaucoma. The development of 3D printed lenses can effectively overcome drawbacks of existing approaches by using biocompatible medical grade polymers that provide sustained drug release of timolol maleate for extended periods. Methods Hot melt extrusion was coupled with fusion deposition modelling (FDM) to produce printable filaments of ethylene-vinyl acetate copolymer–polylactic acid blends at various ratios loaded with timolol maleate. Physicochemical and mechanical characterisation of the printed filaments was used to optimise the printing of the contact lenses Key findings 3D printed lenses with an aperture (opening) and specified dimensions could be printed using FDM technology. The lenses presented a smooth surface with good printing resolution while providing sustained release of timolol maleate over 3 days. The findings of this study can be used for the development of personalised DECL in the future.en-US3D printingfusion deposition modellinghot melt extrusioncontact lensesmedical biodegradableglaucomaArticlehttps://doi.org/10.1093/jpp/rgab173